Search research articles
Contact Us
Filters
Showing results (771-780 of 870) with videos related to
Page
of 87
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial
John J Coen, Joseph P Rodgers, Philip J Saylor, et al.
The Journal of Urology
|
January 15, 2018
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options
Martin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.
The Journal of Urology
|
December 6, 2017
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
Martin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2018
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial
John J Coen, Peixin Zhang, Philip J Saylor, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2000
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406
J M Michalski, J A Purdy, K Winter, et al.
Cancer
|
February 26, 2013
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer
Phillip J Gray, Jonathan J Paly, Beow Y Yeap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2017
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
Neurobiology of Disease
|
December 15, 2019
Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease
Michael X Henderson, Dustin J Covell, Charlotte Hiu-Yan Chung, et al.
Cancer
|
January 3, 2014
Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer
Bradford S Hoppe, Jeff M Michalski, Nancy P Mendenhall, et al.
Cloning and Stem Cells
|
February 4, 2009
Reprogramming of human somatic cells using human and animal oocytes
Young Chung, Colin E Bishop, Nathan R Treff, et al.
Page
of 87
Search research articles
Search
Showing results (771-780 of 870) with videos related to
Sort By:
Page
of 87
International Journal of Radiation Oncology, Biology, Physics
|
August 15, 2024
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial
John J Coen, Joseph P Rodgers, Philip J Saylor, et al.
The Journal of Urology
|
January 15, 2018
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options
Martin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.
The Journal of Urology
|
December 6, 2017
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
Martin G Sanda, Jeffrey A Cadeddu, Erin Kirkby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2018
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial
John J Coen, Peixin Zhang, Philip J Saylor, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2000
Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406
J M Michalski, J A Purdy, K Winter, et al.
Cancer
|
February 26, 2013
Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer
Phillip J Gray, Jonathan J Paly, Beow Y Yeap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2017
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
Neurobiology of Disease
|
December 15, 2019
Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease
Michael X Henderson, Dustin J Covell, Charlotte Hiu-Yan Chung, et al.
Cancer
|
January 3, 2014
Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer
Bradford S Hoppe, Jeff M Michalski, Nancy P Mendenhall, et al.
Cloning and Stem Cells
|
February 4, 2009
Reprogramming of human somatic cells using human and animal oocytes
Young Chung, Colin E Bishop, Nathan R Treff, et al.
Page
of 87